It was reported that a (b)(6) female patient underwent a redo ablation procedure with an unknown thermocool smart touch sf catheter and developed pericarditis requiring medication as intervention.Originally it was reported that after a redo ablation procedure the patient developed pericarditis and no medical or surgical intervention was required.The patient was kept in overnight for monitoring purposes.The issue resolved without sequelae.The principal investigator assessed the event as moderate in severity, serious, unrelated to the study device and possibly related to a repeated study.In the opinion of the investigator, this event was anticipated.On 2/5/2019, additional information was received that the repeat ablation procedure was most probably done with an stsf catheter.However, the catalog and lot # are not available.Since there was originally no evidence that medical intervention, surgical intervention, or prolonged hospitalization was required for treatment, the observed pericarditis was assessed as not mdr reportable.This event is being reported because on 4/12/2019, we received clarification that as a result of the pericarditis, an unspecified medication was administered.The issue of pericarditis requiring medication has been assessed as mdr reportable.The awareness date has been reset to 4/12/2019.
|